USPTO serial 97419938
EMBER LIFESCIENCES
Reviewed by CopyMark Law Group
Status 733Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- LEVINE, HOWARD B
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with EMBER LIFESCIENCES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,143*
Plus Government fees of $1,050
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Westlake Village, CA, US
WESTLAKE VILLAGE, CA, US
Westlake Village, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jonathan A. Hyman
Jonathan A. Hyman KNOBBE, MARTENS, OLSON & BEAR, LLP2040 MAIN STREET, 14TH FLOORIRVINE, CA 92614United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Active and passive transport boxes for medical purposes, namely, vaccines, blood, blood components, blood plasma, tissues, DNAs, laboratory and medical probes, biological probes, pharmaceuticals, drugs, cells, and organs; Incubators for medical purposes, namely, for temperature sensitive medical, pharmaceutical and laboratory items such as vaccines, blood, blood components, blood plasma, tissues, DNAs, laboratory and medical probes, biological probes, pharmaceuticals, drugs, cells, and organs; Refrigerating apparatus for storage of medicines for medical use; Temperature-controlled portable insulated containers for storage of medicines for medical use; Temperature controlled containers for medical use; portable thermoelectric cooling and heating containers for medical use; All the foregoing sold with or without embedded software and firmware for communicating and tracking temperature, humidity, location, pressure, and accelerometer event data and for controlling, reporting, and monitoring the temperature, humidity, and pressure, of the unit | ACTIVE | — |
| 011 | Hot-and-cold temperature-controlled portable insulated containers for medical use for storage of vaccines, blood, blood components, blood plasma, tissues, DNAs, laboratory and medical probes, biological probes, pharmaceuticals, drugs, cells, and organs; Temperature-controlled portable insulated beverage containers; Temperature controlled beverage storage containers; Temperature-controlled portable insulated cups and mugs; Temperature-controlled portable insulated beverage containers containing heating elements; Temperature-controlled portable insulated cups and mugs containing heating elements; Temperature-controlled portable insulated beverage storage containers containing heating elements; Electric hot cups and mugs for keeping beverages warm; Electrically heated liquid containers for keeping beverages warm; beverage-cooling apparatus; Portable thermoelectric cooling and heating containers for beverages; All the foregoing sold with or without embedded software and firmware for communicating temperature data and for controlling, reporting, and monitoring the temperature of the unit; Temperature-controlled portable insulated beverage containers containing phase change materials; Temperature-controlled portable insulated beverage containers containing cooling elements; Temperature-controlled portable insulated cups and mugs containing phase change materials; Temperature-controlled portable insulated cups and mugs containing phase cooling elements; Temperature-controlled portable insulated beverage storage containers containing phase change materials; Temperature-controlled portable insulated beverage storage containers containing cooling elements; Temperature-controlled portable insulated containers for storage of vaccines, blood, blood components, blood plasma, tissues, DNAs, laboratory and medical probes, biological probes, pharmaceuticals, drugs, cells, and organs and for temperature sensitive goods including food and beverages; Electric cool boxes; Electric heating boxes; Electric portable active and passive cold boxes; electric portable active and passive heating boxes; refrigerating apparatus for storage of food; Temperature controlled food storage containers; Temperature-controlled portable insulated food containers; Temperature-controlled portable insulated baby bottles; Temperature-controlled portable insulated baby bottles containing heating elements and phase change materials; Temperature-controlled portable insulated baby bottles containing cooling elements and phase change materials; Temperature-controlled portable insulated food containers containing heating elements and phase change materials; Temperature-controlled portable insulated food containers containing cooling elements and phase change materials; Temperature-controlled portable insulated food storage containers containing heating elements and phase change materials; Temperature-controlled portable insulated food storage containers containing cooling elements and phase change materials; Electrically heated baby bottles for keeping beverages warm; portable thermoelectric cooling and heating containers for food; Portable thermoelectric cooling and heating containers for beverages; Electrically cooled baby bottles for keeping beverages cool; Electrically cooled cups and mugs for keeping beverages cool; Electrically cooled liquid containers for keeping beverages cool; Refrigerated shipping containers; All the foregoing sold with or without embedded software and firmware for communicating and tracking temperature, humidity, location, pressure, and accelerometer event data and for controlling, reporting, and monitoring the temperature, humidity, and pressure, of the unit; All the foregoing for use in the fields of health care, infant and childcare, temperature-controlled apparel and wearables, and shipping and logistics | ACTIVE | — |
| 035 | Inventory management; Freight management services, namely, shipment processing, preparing shipping documents and invoices, tracking documents, packages and freight namely, vaccines, blood, blood components, blood plasma, tissues, DNAs, laboratory and medical probes, biological probes, pharmaceuticals, drugs, cells, and organs, over computer networks for business purposes; Freight management services, namely, shipment processing, tracking packages and freight over computer networks for business purposes; providing tracking services and information concerning tracking of assets in transit, namely, cargo and delivery containers for business inventory purposes; providing electronic tracking of freight information to others for business administration purposes; tracking, locating and monitoring of transport containers for commercial purposes; Real time business management services | ACTIVE | — |
| 037 | Technical support services, namely, providing technical advice in repair and maintenance of transport containers; Providing a website featuring information in the field of repair and maintenance of transport containers | ACTIVE | — |
| 039 | Shipping of goods; delivery of goods; Arranging pickup, transportation, and delivery of vaccines, blood, blood components, blood plasma, tissues, DNAs, laboratory and medical probes, biological probes, pharmaceuticals, drugs, cells, and organs; Pharmaceutical drug delivery services; Delivery of vaccines, blood, blood components, blood plasma, tissues, DNAs, laboratory and medical probes, biological probes, pharmaceuticals, drugs, cells, and organs; Providing a website featuring information in the field of delivery of vaccines, blood, blood components, blood plasma, tissues, DNAs, laboratory and medical probes, biological probes, pharmaceuticals, drugs, cells, and organs; Arranging the transportation of goods for others | ACTIVE | — |
| 042 | Providing temporary use of non-downloadable software for inventory management and tracking freight; Providing temporary use of non-downloadable software for tracking the delivery of vaccines, blood, blood components, blood plasma, tissues, DNAs, laboratory and medical probes, biological probes, pharmaceuticals, drugs, cells, and organs | ACTIVE | — |
| 044 | Medical consultation in the field of prescription medicine adherence by patients | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by EMBER TECHNOLOGIES, INC.
- Other trademarks owned by EMBER LIFESCIENCES, INC.
- Other trademarks owned by EMBER TECHNOLOGIES, INC.
- Other trademarks in Class 010
- Other trademarks in Class 011
- Other trademarks in Class 035
- Other trademarks in Class 037
- Other trademarks in Class 039
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named EMBER LIFESCIENCES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 18, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 18, 2026 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Aug 17, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jun 10, 2026 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jun 4, 2026 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jun 4, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 2, 2026 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Nov 27, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 26, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Nov 26, 2025 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 26, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 15, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 28, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 28, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 28, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 3, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 27, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 26, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 26, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 4, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 9, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 9, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 20, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 5, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 14, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 14, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 14, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 10, 2023 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Nov 10, 2023 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Aug 15, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 15, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 15, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 11, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 10, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 10, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 5, 2023 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Apr 5, 2023 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Jan 10, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 10, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 10, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 14, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 13, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 13, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 16, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 16, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 16, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 16, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 10, 2022 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Jun 9, 2022 | ALIE | ASSIGNED TO LIE | — |
| Jun 2, 2022 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| May 25, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 23, 2022 | NWAP | NEW APPLICATION ENTERED | — |